From May 11 to 14, 2025, WCC Biomedical had the privilege of participating as featured speakers and an exhibitor at the Microneedles Conference 2025, held in Brisbane, Australia. Widely regarded as the premier international event for microneedle innovation, this year’s conference brought together hundreds of thought leaders, researchers, pharmaceutical companies, and global health organizations from around the world to explore the latest developments in microneedle technology.
At this year’s forum, WCC introduced our company to an international audience and showcased our scalable precision loading and coating breakthrough through three engaging presentations focused on:
- WCC’s mRNA MAPs
- WCC’s DS MAPs
- MINIMAP™ Impact to Scaling Up Microarray Patches Production
Our presentations at the conference attracted strong interest from stakeholders across sectors, including pharmaceutical companies, academic institutions, government agencies, and non-profit organizations. Many visited our exhibition booth and expressed interest in future collaboration—especially around our proprietary MINIMAP™ platform, which emerged as a game-changing advancement in the microneedle space.
MINIMAP™ sparked particularly enthusiastic discussions. Designed for speed, flexibility, and accessibility, it enables rapid screening, supports small-scale patch production, and—most importantly—is fully portable. This makes it ideal for deployment at the point of care, especially in remote or underserved areas, dramatically expanding the reach of microarray patches technology.
We were thrilled by the level of engagement and collaborative energy that emerged during the conference. WCC remains committed to pushing the boundaries of microneedle innovation and expanding global access to advanced drug and vaccine delivery systems.
If you’re interested in learning more about our technology or exploring collaboration opportunities, we would be delighted to connect with you!
